GPR 15
Alternative Names: GPR-15Latest Information Update: 26 Apr 2023
At a glance
- Originator Orion Biotechnology Canada
- Class Antineoplastics; Recombinant proteins
- Mechanism of Action G protein-coupled receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Cancer
Most Recent Events
- 11 Apr 2023 Early research in Cancer in Canada (unspecified route) (Orion Biotechnology pipeline, April 2023)